Company news

TherapeuticsMD, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

TherapeuticsMD and Theramex Announce the Approval of BIJUVE® Capsules Indicated for Hormone Replacement Therapy in the United Kingdom and Under the Trade Name BIJUVA® in Belgium

April 7, 2021

TherapeuticsMD Announces Fourth Quarter and Full-Year 2020 Financial Results

March 1, 2021

TherapeuticsMD Announces Participation in Upcoming Investor Conferences

February 28, 2021

TherapeuticsMD to Report Fourth Quarter 2020 Results on March 2, 2021

February 22, 2021

TherapeuticsMD Announces Closing of its Underwritten Public Offering of Common Stock

February 15, 2021

TherapeuticsMD Announces Pricing of $110 Million Public Offering of Common Stock

February 10, 2021

TherapeuticsMD Announces Underwritten Public Offering of its Common Stock

February 9, 2021

Comedian Whitney Cummings Partners with TherapeuticsMD to Launch “Just Say Vagina”

December 14, 2020

TherapeuticsMD Announces Participation in the Stifel 2020 Virtual Healthcare Conference

November 12, 2020

TherapeuticsMD Announces Pricing of $30 Million Public Offering of Common Stock

November 9, 2020

TherapeuticsMD® Announces Third Quarter 2020 Financial Results

November 8, 2020

TherapeuticsMD to Report Third Quarter 2020 Results on November 9, 2020

October 28, 2020

TherapeuticsMD Supports the Importance of Empowering Women to Make Informed Choices about their Sexual and Reproductive Health

October 8, 2020

TherapeuticsMD Provides Update on Third Quarter Progress

September 24, 2020

Knight and TherapeuticsMD Announce Health Canada Approval of BIJUVA®

September 20, 2020

TherapeuticsMD Announces Participation at Two Upcoming Virtual Investor Conferences

September 9, 2020

TherapeuticsMD Announces Patent Updates for ANNOVERA®

September 8, 2020

Knight and TherapeuticsMD Announce Health Canada Approval of IMVEXXY®

August 24, 2020

TherapeuticsMD® Announces Second Quarter 2020 Financial Results

August 5, 2020

TherapeuticsMD to Report Second Quarter 2020 Results on August 6, 2020

July 28, 2020

TherapeuticsMD and Nurx Expand Access to ANNOVERA®

July 14, 2020

TherapeuticsMD Announces Appointment of James C. D’Arecca as Chief Financial Officer and Retirement of Daniel A. Cartwright as Chief Financial Officer

May 31, 2020

TherapeuticsMD Announces Participation at the BofA Securities 2020 Health Care Conference

May 7, 2020

TherapeuticsMD Announces First Quarter 2020 Financial Results

May 5, 2020

TherapeuticsMD Announces Issuance of First Orange Book Listable U.S. Patent for ANNOVERA®

April 28, 2020

TherapeuticsMD to Report First Quarter 2020 Results on May 6, 2020

April 27, 2020

TherapeuticsMD Further Strengthens Board with Appointment of New Independent Director

April 21, 2020

TherapeuticsMD Provides COVID-19-Related Business Update

March 25, 2020

TherapeuticsMD Strengthens Board with Appointment of Industry Leaders

March 23, 2020

TherapeuticsMD Provides Business Update on COVID-19 Pandemic

March 15, 2020

TherapeuticsMD Announces Participation at the Cowen 40th Annual Healthcare Conference

February 26, 2020

TherapeuticsMD Announces Fourth Quarter and Full-Year 2019 Financial Results

February 19, 2020

TherapeuticsMD and Afaxys Enter Into Agreement to Expand Access to ANNOVERA® in the U.S. Public Health Sector

February 12, 2020

TherapeuticsMD to Report Fourth Quarter 2019 Results on February 20, 2020

February 9, 2020

TherapeuticsMD Announces Submission of New Drug Application Prior Approval Efficacy Supplement to the U.S. Food and Drug Administration for Lower Dose of BIJUVA®

February 2, 2020

TherapeuticsMD, An Innovative Women's Healthcare Company, And PlushCare, A Virtual Health Platform, Announce Enhanced Access To Women's Health Products

January 6, 2020

TherapeuticsMD, an Innovative Women’s Healthcare Company, and PlushCare, a Virtual Health Platform, Announce Enhanced Access to Women’s Health Products

January 6, 2020

TherapeuticsMD Announces Participation at the JP Morgan Healthcare Conference

January 5, 2020

TherapeuticsMD Announces Amendment to Term Loan Financing Facility with TPG Sixth Street Partners

December 29, 2019

Knight and TherapeuticsMD Announce Filing of New Drug Submission for BIJUVA® in Canada

November 25, 2019

TherapeuticsMD Announces Participation at the Stifel 2019 Healthcare Conference

November 11, 2019

TherapeuticsMD Announces Third Quarter 2019 Financial Results

November 5, 2019

TherapeuticsMD to Report Third Quarter 2019 Results on November 6, 2019

October 31, 2019

Knight and TherapeuticsMD Announce Filing of New Drug Submission for Joyesta™ in Canada

October 29, 2019

TherapeuticsMD Announces Closing of Its Underwritten Public Offering of Common Stock

October 28, 2019

TherapeuticsMD Announces Pricing of Its Underwritten Public Offering of 26 Million Shares of Common Stock

October 23, 2019

TherapeuticsMD Announces Proposed Underwritten Public Offering of 22 Million Shares of Common Stock

October 22, 2019

TherapeuticsMD Announces Estimated Third Quarter 2019 Financial Results

October 22, 2019

TherapeuticsMD Announces Presentations on ANNOVERA™ at the 2019 Annual Meeting of the American Society for Reproductive Medicine

October 10, 2019

TherapeuticsMD Announces Multiple Presentations Related to IMVEXXY® and BIJUVA® at the 2019 Annual Meeting of the North American Menopause Society

September 23, 2019

← Newer news releases

Calls

The 5 newest of 7 calls. Every call is listed under its year.

Decks

The 5 newest of 78 decks. Every deck is listed under its year.